ADAMTS2 Gene Mutation Analysis
Hepatitis D Virus (HDV) Antibody, Total
Citalopram, Urine
Endomysial (EMA) Antibody, IgG
CD4 Lymphocyte Count
ANKK1/DRD2
COL1A1/COL1A2 Genes Variations Analysis
Oncotype DX, Breast Cancer
Aspergillus DNA, Qualitative, Real-Time PCR, BAL
HER2/neu (ERBB2) Gene Amplification, FISH, Gastroesophageal Cancer,
LDS
Sign up
Log in
LDS
/
Medical Tests
/
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Medical Test
Methodology
Access to
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
is restricted.
Sign up now